Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ClearPoint Neuro Inc (CLPT) vs Moody's Corporation (MCO) Price & Performance

ClearPoint Neuro IncTrade
Moody's CorporationTrade

Price performance (Past 24H)

Key statistics

ClearPoint Neuro Inc vs Moody's Corporation — how do they compare? ClearPoint Neuro Inc trades at $14.86 (market cap $454.21M), while Moody's Corporation trades at $475 (market cap $82.52B). The key difference: Moody's Corporation is far larger — about 181.7× ClearPoint Neuro Inc's market cap, and Moody's Corporation pays a 0.86% dividend while ClearPoint Neuro Inc pays none. Which is the better fit depends on your goals.

CLPTMCO
Market Cap
$454.21M$82.52B
Sector
HealthFinancials
52-Week High
$29.60$539.61
52-Week Low
$8.66$412.23
Enterprise Value
$488.79M$88.54B
Dividend Yield
0.86%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About ClearPoint Neuro Inc

ClearPoint Neuro provides medical devices and software for precise neurosurgical procedures. Its navigation systems allow surgeons to perform minimally invasive brain and spine surgeries with extreme accuracy.

Read more on CLPT

About Moody's Corporation

Moody's, along with S&P Ratings, is a leading provider of credit ratings on fixed income securities. Moody's ratings segment, known as Moody's Investors Service or MIS, includes corporates, structured finance, financial institutions, and public finance ratings. MIS represents a majority of the firm's revenue and profits. Moody's other segment is Moody's Analytics and consists of Research, Data, and Analytics or RD&A and Enterprise Risk Solutions or ERS. RD&A's products include credit research, quantitative credit scores, economic research, business intelligence, know your customer (KYC) tools, commercial real estate data and analytical tools, and training services. ERS includes risk management software solutions to financial institutions.

Read more on MCO